BIOMAT Database Logo BIOMAT Database Logo

Identification of an aldose reductase inhibitor site by affinity labeling. 1995

P F Kador, and Y S Lee, and L Rodriguez, and S Sato, and A Bartoszko-Malik, and Y S Abdel-Ghany, and D D Miller
Laboratory of Ocular Therapeutics, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Animal studies indicate that aldose reductase inhibitors represent a pharmacological method for inhibiting the onset of diabetic complications that is independent of blood sugar control. This has spurred the development of aldose reductase inhibitors (ARIs). To facilitate the rational development of more potent and direct ARIs, more specific knowledge of the structural and pharmacophoric requirements of the site at which ARIs interact are required. Co-crystallization of human placental aldose reductase with the inhibitor zopolrestat has been reported to result in a complex where the inhibitor is almost completely sequestered in the hydrophobic pocket which forms the substrate site. Zopolrestat's observed location, which makes the active site pocket inaccessible to solvent or further productive binding of substrate, is not supported by published inhibitor structure-activity relationships (SAR) studies or kinetic results which indicate that aldose reductase inhibitors such as zopolrestat are either non-competitive or uncompetitive inhibitors. Using a 5-iodoacetamido analog of alrestatin as an affinity labeled aldose reductase inhibitor, an inhibitor binding site on aldose reductase has been located. This inhibitor binding site contains a number of pharmacophoric elements previously proposed for the inhibitor site. Its location and composition is consistent with reported kinetic data, SAR observations, stereochemical requirements, and quantum chemical calculations.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007908 Lens, Crystalline A transparent, biconvex structure of the EYE, enclosed in a capsule and situated behind the IRIS and in front of the vitreous humor (VITREOUS BODY). It is slightly overlapped at its margin by the ciliary processes. Adaptation by the CILIARY BODY is crucial for OCULAR ACCOMMODATION. Eye Lens,Lens, Eye,Crystalline Lens
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P F Kador, and Y S Lee, and L Rodriguez, and S Sato, and A Bartoszko-Malik, and Y S Abdel-Ghany, and D D Miller
The aldose reductase inhibitor site.
April 1986, Metabolism: clinical and experimental,
P F Kador, and Y S Lee, and L Rodriguez, and S Sato, and A Bartoszko-Malik, and Y S Abdel-Ghany, and D D Miller
Pharmacophor requirements of the aldose reductase inhibitor site.
November 1983, Molecular pharmacology,
P F Kador, and Y S Lee, and L Rodriguez, and S Sato, and A Bartoszko-Malik, and Y S Abdel-Ghany, and D D Miller
X-ray affinity and photoaffinity inhibitor of aldose reductase.
January 1986, Journal of ocular pharmacology,
P F Kador, and Y S Lee, and L Rodriguez, and S Sato, and A Bartoszko-Malik, and Y S Abdel-Ghany, and D D Miller
[Aldose reductase inhibitor].
November 2010, Nihon rinsho. Japanese journal of clinical medicine,
P F Kador, and Y S Lee, and L Rodriguez, and S Sato, and A Bartoszko-Malik, and Y S Abdel-Ghany, and D D Miller
Aldose reductase from human psoas muscle. Affinity labeling of an active site lysine by pyridoxal 5'-phosphate and pyridoxal 5'-diphospho-5'-adenosine.
February 1989, The Journal of biological chemistry,
P F Kador, and Y S Lee, and L Rodriguez, and S Sato, and A Bartoszko-Malik, and Y S Abdel-Ghany, and D D Miller
Probing the inhibitor-binding site of aldose reductase with site-directed mutagenesis.
September 1998, European journal of biochemistry,
P F Kador, and Y S Lee, and L Rodriguez, and S Sato, and A Bartoszko-Malik, and Y S Abdel-Ghany, and D D Miller
Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
January 1985, Diabetes,
P F Kador, and Y S Lee, and L Rodriguez, and S Sato, and A Bartoszko-Malik, and Y S Abdel-Ghany, and D D Miller
Maleic acid is an aldose reductase inhibitor.
January 1997, Neurobiology (Budapest, Hungary),
P F Kador, and Y S Lee, and L Rodriguez, and S Sato, and A Bartoszko-Malik, and Y S Abdel-Ghany, and D D Miller
Topical aldose reductase inhibitor.
December 1995, The British journal of ophthalmology,
P F Kador, and Y S Lee, and L Rodriguez, and S Sato, and A Bartoszko-Malik, and Y S Abdel-Ghany, and D D Miller
Identification of an active-site residue in yeast invertase by affinity labeling and site-directed mutagenesis.
July 1990, The Journal of biological chemistry,
Copied contents to your clipboard!